HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Secoisolariciresinol diglycoside, a flaxseed lignan, exerts analgesic effects in a mouse model of type 1 diabetes: Engagement of antioxidant mechanism.

Abstract
Peripheral painful neuropathy is one of the most common complications in diabetes and necessitates improved treatment. Secoisolariciresinol diglycoside (SDG), a predominant lignan in flaxseed, has been shown in our previous studies to exert antidepressant-like effect. As antidepressant drugs are clinically used to treat chronic neuropathic pain, this work aimed to investigate the potential analgesic efficacy of SDG against diabetic neuropathic pain in a mouse model of type 1 diabetes. We subjected mice to diabetes by a single intraperitoneal (i.p.) injection of streptozotocin (STZ, 200 mg/kg), and Hargreaves test or von Frey test was used to assess thermal hyperalgesia or mechanical allodynia, respectively. Chronic instead of acute SDG treatment (3, 10 or 30 mg/kg, p.o., twice per day for three weeks) ameliorated thermal hyperalgesia and mechanical allodynia in diabetic mice, and these analgesic actions persisted about three days when SDG treatment was terminated. Although chronic treatment of SDG to diabetic mice did not impact on the symptom of hyperglycemia, it greatly attenuated excessive oxidative stress in sciatic nerve and spinal cord tissues, and partially counteracted the condition of weight decrease. Furthermore, the analgesic actions of SDG were abolished by co-treatment with the reactive oxygen species donor tert-butyl hydroperoxide (t-BOOH), but potentiated by the reactive oxygen species scavenger phenyl-N-tert-butylnitrone (PBN). These findings indicate that chronic SDG treatment can correct neuropathic hyperalgesia and allodynia in mice with type 1 diabetes. Mechanistically, the analgesic actions of SDG in diabetic mice may be associated with its antioxidant activity.
AuthorsPei Hu, Qi-Yong Mei, Li Ma, Wu-Geng Cui, Wen-Hua Zhou, Dong-Sheng Zhou, Qing Zhao, Dong-Ying Xu, Xin Zhao, Qin Lu, Zhen-Yu Hu
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 767 Pg. 183-92 (Nov 15 2015) ISSN: 1879-0712 [Electronic] Netherlands
PMID26494631 (Publication Type: Journal Article)
CopyrightCopyright © 2015. Published by Elsevier B.V.
Chemical References
  • Analgesics
  • Antioxidants
  • Butylene Glycols
  • Cyclic N-Oxides
  • Glycosides
  • Lignans
  • phenyl-N-tert-butylnitrone
  • tert-Butylhydroperoxide
  • secoisolariciresinol
Topics
  • Analgesics (pharmacology, therapeutic use)
  • Animals
  • Antioxidants (metabolism)
  • Butylene Glycols (antagonists & inhibitors, pharmacology, therapeutic use)
  • Cyclic N-Oxides (pharmacology)
  • Diabetes Mellitus, Type 1 (complications, drug therapy, metabolism)
  • Diabetic Neuropathies (chemically induced, complications, drug therapy, metabolism)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Flax (chemistry)
  • Glycosides (antagonists & inhibitors, pharmacology, therapeutic use)
  • Hyperalgesia (complications, drug therapy, metabolism)
  • Lignans (antagonists & inhibitors, pharmacology, therapeutic use)
  • Male
  • Mice
  • Neuralgia (complications, drug therapy)
  • Sciatic Nerve (metabolism)
  • Spinal Cord (metabolism)
  • tert-Butylhydroperoxide (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: